TrialPediatric obesity2019

Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.

Lucy D Mastrandrea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.